Home > Insider Trading > Filing (0001525587-12-000016)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1311230	Solazyme Inc	SZYM	Industrial Organic Chemicals (2860)	331077078

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1333277	T Paul Quinlan	Solazyme, Inc. 225 Gateway Boulevard South San Francisco CA 94080	General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-02-13	2,000	$2.35	32,000	No	4	M	Direct
Common Stock	Disposition	2012-02-13	2,000	$11.30	30,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee stock option (right to buy)	Acquisiton	2012-02-11	100,000	$0.00	100,000	$11.49
Common Stock	Employee stock option (right to buy)	Disposition	2012-02-13	2,000	$0.00	2,000	$2.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
100,000		2022-02-10	No	4	A	Direct
116,000		2020-06-13	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pusuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2011 and amended on December 9, 2011.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.25 to $11.37, inclusive. The reporting person undertakes to provide Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests as to 1/48 of the underlying shares monthly from January 1, 2012.
All shares immediately exercisable. The original option grant vests as to 1/4 of the shares on May 24, 2011 and 1/36 per month thereafter.